In conclusion, this research demonstrated that administration of FGF21 reduces the production of α-SMA through inhibition of succinate -GPR91 signaling in HSCs and improves hepatic steatosis and fibrosis in an MCD diet -induce mouse model. Here, FGF21 is linked to fatty liver disease.